SCM

Sarissa Capital Management Portfolio holdings

AUM $154M
1-Year Est. Return 6.05%
This Quarter Est. Return
1 Year Est. Return
-6.05%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$514M
AUM Growth
+$109M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
21
New
Increased
Reduced
Closed

Top Buys

1
+$95M
2
+$11.7M
3
+$2.95M
4
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$1.88M
5
AEGR
Aegerion Pharmaceuticals
AEGR
+$253K

Top Sells

1
+$19.8M
2
+$3.58M
3
+$419K
4
RPRX
Repros Therapeutics Inc.
RPRX
+$159K
5
CARM
Carisma Therapeutics
CARM
+$99K

Sector Composition

1 Healthcare 88.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$95M 18.46%
+310,000
2
$93.6M 18.2%
1,580,000
3
$80.3M 15.61%
12,850,000
4
$58.5M 11.38%
1,567,000
5
$40.9M 7.95%
575,000
6
$40.9M 7.95%
532,200
+152,200
7
$36.3M 7.06%
675,000
+35,000
8
$26.1M 5.07%
2,580,000
+25,000
9
$14.6M 2.84%
90,000
10
$9.97M 1.94%
448,000
11
$6.46M 1.26%
6
12
$2.95M 0.57%
+700,000
13
$2.92M 0.57%
231,376
14
$2.63M 0.51%
257,394
15
$1.4M 0.27%
31,000
16
$1.21M 0.24%
1,001,000
-131,367
17
– –
-2,060
18
– –
-800
19
– –
-419,200
20
– –
-689,091